Harsco Corporation (HSC) Tops Q3 EPS by 15c; Offers Guidance
Get Alerts HSC Hot Sheet
Price: $9.15 --0%
Financial Fact:
Research and development expenses: 910K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: 910K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harsco Corporation (NYSE: HSC) reported Q3 EPS of $0.10, $0.15 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $487 million versus the consensus estimate of $478.94 million.
GUIDANCE:
Harsco Corporation sees Q4 2022 EPS of ($0.02)-($0.12), versus the consensus of ($0.04).
Harsco Corporation sees FY2022 EPS of ($0.02)-$0.08, versus the consensus of ($0.10).
For earnings history and earnings-related data on Harsco Corporation (HSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share